High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome

Sohag University240 enrolled

Overview

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients

Observational study conducted at coronary care unit(CCU) in sohag university hospital It included patients with ACS diagnosed according to AHA/ACCF guidelines (according to symptoms, ECG findings and serum troponin levels), who had admitted to the CCU. Venous blood samples were instantly collected on admission to the hospital. hs-CRP , serum albumin level were measured. hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) In-hospital MACE was regarded as the end point of our study. It was defined as acute heart failure, cardiogenic shock, reinfarction, all-cause death, serious arrhythmia and cardiac death

Study Type

OBSERVATIONAL

Enrollment

240

Conditions

Acute Coronary Syndrome

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients aged 18 Year or older presented by ACS not candidet for primary percutaneus coronary intervention ( PCI ) . Exclusion Criteria: * • Patients aged \< 18 years old * Patients who have eGFR \<60 ml/kg /m2 * Patients who have malignancies * Patients who have chronic heart failure (NYHA class \>II) * Pateints who have chronic liver disease * Patients who have nephrotic syndrome * Patients who have acute cerebrovascular stroke * Pregnant women * Patients who have recent infection

Locations (1)

Sohag faculty of medicine

Sohag, Egypt

RECRUITING

Outcomes

Primary Outcomes

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in acute coronary syndrom patients

Venous blood samples were collected on admission to the hospital. hs-CRP , serum albumin level were measured. hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR)

Time frame: at time of admission in hospital

Central Contacts

Amira Elbasuony, resident

CONTACT

01113695925 amiraelbadawy518@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.